347 related articles for article (PubMed ID: 21389155)
1. Comparison of strain typing results for Clostridium difficile isolates from North America.
Tenover FC; Akerlund T; Gerding DN; Goering RV; Boström T; Jonsson AM; Wong E; Wortman AT; Persing DH
J Clin Microbiol; 2011 May; 49(5):1831-7. PubMed ID: 21389155
[TBL] [Abstract][Full Text] [Related]
2. Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing.
Killgore G; Thompson A; Johnson S; Brazier J; Kuijper E; Pepin J; Frost EH; Savelkoul P; Nicholson B; van den Berg RJ; Kato H; Sambol SP; Zukowski W; Woods C; Limbago B; Gerding DN; McDonald LC
J Clin Microbiol; 2008 Feb; 46(2):431-7. PubMed ID: 18039796
[TBL] [Abstract][Full Text] [Related]
3. Correlation between restriction endonuclease analysis and PCR ribotyping for the identification of Clostridioides (Clostridium) difficile clinical strains.
Kociolek LK; Perdue ER; Fawley WN; Wilcox MH; Gerding DN; Johnson S
Anaerobe; 2018 Dec; 54():1-7. PubMed ID: 30009944
[TBL] [Abstract][Full Text] [Related]
4. Comparison of restriction endonuclease analysis, ribotyping, and pulsed-field gel electrophoresis for molecular differentiation of Clostridium difficile strains.
Kristjánsson M; Samore MH; Gerding DN; DeGirolami PC; Bettin KM; Karchmer AW; Arbeit RD
J Clin Microbiol; 1994 Aug; 32(8):1963-9. PubMed ID: 7989550
[TBL] [Abstract][Full Text] [Related]
5. Rapid spread of Clostridium difficile NAP1/027/ST1 in Chile confirms the emergence of the epidemic strain in Latin America.
Aguayo C; Flores R; Lévesque S; Araya P; Ulloa S; Lagos J; Hormazabal JC; Tognarelli J; Ibáñez D; Pidal P; Duery O; Olivares B; Fernández J
Epidemiol Infect; 2015 Oct; 143(14):3069-73. PubMed ID: 25687254
[TBL] [Abstract][Full Text] [Related]
6. Challenges for standardization of Clostridium difficile typing methods.
Huber CA; Foster NF; Riley TV; Paterson DL
J Clin Microbiol; 2013 Sep; 51(9):2810-4. PubMed ID: 23784128
[TBL] [Abstract][Full Text] [Related]
7. Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes.
Sirard S; Valiquette L; Fortier LC
J Clin Microbiol; 2011 Dec; 49(12):4040-6. PubMed ID: 21956985
[TBL] [Abstract][Full Text] [Related]
8. Comparison of repetitive extragenic palindromic sequence-based PCR with PCR ribotyping and pulsed-field gel electrophoresis in studying the clonality of Clostridium difficile.
Pasanen T; Kotila SM; Horsma J; Virolainen A; Jalava J; Ibrahem S; Antikainen J; Mero S; Tarkka E; Vaara M; Tissari P
Clin Microbiol Infect; 2011 Feb; 17(2):166-75. PubMed ID: 20331683
[TBL] [Abstract][Full Text] [Related]
9. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from two Korean hospitals.
Nicholas A; Kim YK; Lee WK; Selasi GN; Na SH; Kwon HI; Kim YJ; Lee HS; Song KE; Shin JH; Lee JC
PLoS One; 2017; 12(3):e0174716. PubMed ID: 28355266
[TBL] [Abstract][Full Text] [Related]
10. Use of highly discriminatory fingerprinting to analyze clusters of Clostridium difficile infection cases due to epidemic ribotype 027 strains.
Fawley WN; Freeman J; Smith C; Harmanus C; van den Berg RJ; Kuijper EJ; Wilcox MH
J Clin Microbiol; 2008 Mar; 46(3):954-60. PubMed ID: 18216211
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Clostridioides difficile isolates recovered from two Phase 3 surotomycin treatment trials by restriction endonuclease analysis, PCR ribotyping and antimicrobial susceptibilities.
Cheknis A; Devaris D; Chesnel L; Dale SE; Nary J; Sambol SP; Citron DM; Goering RV; Johnson S
J Antimicrob Chemother; 2020 Nov; 75(11):3120-3125. PubMed ID: 32747931
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital.
Babady NE; Stiles J; Ruggiero P; Khosa P; Huang D; Shuptar S; Kamboj M; Kiehn TE
J Clin Microbiol; 2010 Dec; 48(12):4519-24. PubMed ID: 20943860
[TBL] [Abstract][Full Text] [Related]
13. International typing study of toxin A-negative, toxin B-positive Clostridium difficile variants.
Johnson S; Sambol SP; Brazier JS; Delmée M; Avesani V; Merrigan MM; Gerding DN
J Clin Microbiol; 2003 Apr; 41(4):1543-7. PubMed ID: 12682143
[TBL] [Abstract][Full Text] [Related]
14. Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin.
Figueroa I; Johnson S; Sambol SP; Goldstein EJ; Citron DM; Gerding DN
Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S104-9. PubMed ID: 22752857
[TBL] [Abstract][Full Text] [Related]
15. MALDI-TOF MS: An alternative approach for ribotyping Clostridioides difficile isolates in Brazil.
Carneiro LG; Pinto TCA; Moura H; Barr J; Domingues RMCP; Ferreira EO
Anaerobe; 2021 Jun; 69():102351. PubMed ID: 33621659
[TBL] [Abstract][Full Text] [Related]
16. An epidemic, toxin gene-variant strain of Clostridium difficile.
McDonald LC; Killgore GE; Thompson A; Owens RC; Kazakova SV; Sambol SP; Johnson S; Gerding DN
N Engl J Med; 2005 Dec; 353(23):2433-41. PubMed ID: 16322603
[TBL] [Abstract][Full Text] [Related]
17. Multidrug-resistant North American pulsotype 2 Clostridium difficile was the predominant toxigenic hospital-acquired strain in the province of Manitoba, Canada, in 2006-2007.
Karlowsky JA; Zhanel GG; Hammond GW; Rubinstein E; Wylie J; Du T; Mulvey MR; Alfa MJ
J Med Microbiol; 2012 May; 61(Pt 5):693-700. PubMed ID: 22301615
[TBL] [Abstract][Full Text] [Related]
18. Multilocus variable-number tandem-repeat analysis and multilocus sequence typing reveal genetic relationships among Clostridium difficile isolates genotyped by restriction endonuclease analysis.
Marsh JW; O'Leary MM; Shutt KA; Sambol SP; Johnson S; Gerding DN; Harrison LH
J Clin Microbiol; 2010 Feb; 48(2):412-8. PubMed ID: 19955268
[TBL] [Abstract][Full Text] [Related]
19. Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007.
Cheknis AK; Sambol SP; Davidson DM; Nagaro KJ; Mancini MC; Hidalgo-Arroyo GA; Brazier JS; Johnson S; Gerding DN
Anaerobe; 2009 Dec; 15(6):230-3. PubMed ID: 19737618
[TBL] [Abstract][Full Text] [Related]
20. A modified pulsed-field gel electrophoresis (PFGE) protocol for subtyping previously non-PFGE typeable isolates of Clostridium difficile polymerase chain reaction ribotype 001.
Gal M; Northey G; Brazier JS
J Hosp Infect; 2005 Nov; 61(3):231-6. PubMed ID: 16002184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
